APT Medical Inc. (688617.SS)
CNY 359.11
(-1.08%)
CNY 359.11
(-1.08%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 600.41 Million CNY | 30.96% |
| 2022 | 396.98 Million CNY | 78.42% |
| 2021 | 222.5 Million CNY | 86.28% |
| 2020 | 119.44 Million CNY | 29.7% |
| 2019 | 92.09 Million CNY | 290.21% |
| 2018 | 23.6 Million CNY | -24.16% |
| 2017 | 31.11 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 199.52 Million CNY | -5.58% |
| 2024 Q1 | 144.39 Million CNY | 12.66% |
| 2024 Q2 | 211.31 Million CNY | 46.35% |
| 2023 Q4 | 128.16 Million CNY | -21.28% |
| 2023 Q2 | 176.37 Million CNY | 52.28% |
| 2023 FY | 519.9 Million CNY | 30.96% |
| 2023 Q1 | 115.82 Million CNY | 8.18% |
| 2023 Q3 | 162.8 Million CNY | -7.7% |
| 2022 Q2 | 101.39 Million CNY | 36.76% |
| 2022 Q4 | 107.07 Million CNY | -6.39% |
| 2022 Q3 | 114.38 Million CNY | 12.82% |
| 2022 FY | 396.98 Million CNY | 78.42% |
| 2022 Q1 | 74.13 Million CNY | 99.09% |
| 2021 Q4 | 37.23 Million CNY | -30.99% |
| 2021 FY | 222.5 Million CNY | 86.28% |
| 2021 Q2 | 78.69 Million CNY | 49.6% |
| 2021 Q1 | 52.6 Million CNY | 40.32% |
| 2021 Q3 | 53.96 Million CNY | -31.43% |
| 2020 FY | 119.44 Million CNY | 29.7% |
| 2020 Q4 | 37.49 Million CNY | 6.18% |
| 2020 Q3 | 35.3 Million CNY | -1.82% |
| 2020 Q2 | 35.96 Million CNY | 236.48% |
| 2020 Q1 | 10.68 Million CNY | -54.8% |
| 2019 Q3 | 18.9 Million CNY | 0.0% |
| 2019 FY | 92.09 Million CNY | 290.21% |
| 2019 Q4 | 23.64 Million CNY | 25.08% |
| 2018 FY | 23.6 Million CNY | -24.16% |
| 2017 FY | 31.11 Million CNY | 0.0% |